Article Menu

Export Article

More by Authors Links

Article Data

  • Views 455
  • Dowloads 113

Case Reports

Open Access

A case of ovarian small cell carcinoma of the pulmonary type that was observed as it developed

  • R. Kumasaka1,2
  • Y. Yokoyama2,*,
  • K. Fuchinoue1,2
  • H. Mizunuma2
  • R. Taniguchi1
  • T. Hashimoto1
  • T. Oda1
  • T. Kusumi3

1Department of Obstetrics and Gynecology, Aomori City Hospital, Aomori, Japan

2Department of Obstetrics and Gynecology, Hirosaki University School of Medicine, Hirosaki, Japan

3Department of Pathology, Aomori City Hospital, Aomori, Japan

DOI: 10.12892/ejgo3050.2016 Vol.37,Issue 5,October 2016 pp.710-713

Published: 10 October 2016

*Corresponding Author(s): Y. Yokoyama E-mail: yokoyama@hirosaki-u.ac.jp

PDF (659.9 kB)

Abstract

In the case reported here, the authors observed ovarian small cell carcinoma of the pulmonary type as it developed. The patient was a 48-year-old woman who underwent a hysterectomy for CIN3 in 2007. A year later, the woman underwent screening for ovarian cancer. A gradually growing ovarian mass was noted. This mass was found to be a mixed tumor. This mixed tumor grew to 36 mm in size, and six months later it had enlarged to 119 mm. After surgery, the tumor was pathologically diagnosed as an ovarian small cell carcinoma of the pulmonary type with a neuroendocrine nature that was positive for CD56 and synaptophysin. Postoperatively, the patient received six courses of combined therapy with irinotecan and cisplatin (CPT-P therapy), and the patient has survived diseasefree for over two years. Findings suggested that ovarian small cell carcinoma of the pulmonary type is a type 1 ovarian malignancy that develops through an adenoma-carcinoma sequence.

Keywords

Ovarian small cell carcinoma; Pulmonary type; Type 1 ovarian malignancy; CD56; Synaptophysin; Irinotecan and cisplatin.

Cite and Share

R. Kumasaka,Y. Yokoyama,K. Fuchinoue,H. Mizunuma,R. Taniguchi,T. Hashimoto,T. Oda,T. Kusumi. A case of ovarian small cell carcinoma of the pulmonary type that was observed as it developed. European Journal of Gynaecological Oncology. 2016. 37(5);710-713.

URL:

https://www.ejgo.net/articles/10.12892/ejgo3050.2016

References

[1] Scully R.E.: “Small cell carcinoma of hypercalcemic type”. Int. J. Gynecol. Pathol., 1993, 12, 148.

[2] Kurman R.J., Shih IeM.: “Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications”. Int. J. Gynecol. Pathol., 2008, 27, 151.

[3] Dickersin G.R., Kline I.W., Scully R.E.: “Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases”. Cancer, 1982, 49, 188.

[4] Young R.H., Esther O., Scully R.E.: “Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases”. Am. J. Surg. Pathol., 1994, 18, 1102.

[5] Eichhorn J.H., Young R.H., Scully R.E.: “Primary ovarian small cell carcinoma of pulmonary type. Aclinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases”. Am. J. Surg. Pathol., 1992, 16, 926.

[6] Van der Heijden H.F., Heijdra Y.F.: “Extraplumonary small cell carcinoma”. South Med. J., 2005, 98, 345.

[7] Eichhorn J.H., Young R.H., Scully R.E.: “Nonpulumonary small cell carcinomas of extragenital origin metastatic to the ovary”. Cancer, 1993, 71, 177.

[8] Frazier S.R., Kaplan P.A., Loy T.S.: “The pathology of extrapulumonary small cell carcinoma”. Semin. Oncol., 2007, 34, 30.

[9] Saitoh-Sekiguchi M., Nakamura K., Kojimahara T., Ohta T., Kawagoe J., Ohnuki T., et al.: “Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report”. Anticancer Res., 2007, 27, 2685.

[10] Niimi S., Kiyokawa T., Takakura S., Ochiai K., Tanaka T.: “Recurrent small cell carcinoma of the ovary treated with docetaxel: a casereport”. Int. J. Gynecol. Cancer, 2006, 16, 1944.

[11] Isonishi S., Nishii H., Saitou M., Yasuda M., Kiyokawa T., Fukunaga M., et al.: “Small cell carcinoma of the ovary: clinical and biological study”. Int. J. Clin. Oncol., 2008, 13, 161.

[12] Crowder S., Tuller E.: “Small cell carcinoma of the female genital tract”. Semin. Oncol., 2007, 34, 57.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top